Class Action Claims Actelion Inflated Prices of Bosentan by Blocking Generic Alternatives
November 26, 2018 A proposed class action claims Actelion Pharmaceuticals unlawfully barred generic manufacturers from releasing generic versions of Tracleer, a prescription drug used to treat pulmonary artery hypertension, which would have lowered prices for consumers.